RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
7.67
-0.14 (-1.79%)
Mar 6, 2026, 3:12 PM EST - Market open
RxSight Analyst Ratings
Total Analysts
11
Consensus Rating
Hold
Price Target
$11.50
Upside
+49.93%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $8 → $9 | Hold | Maintains | $8 → $9 | +17.34% | Feb 26, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $11 → $10 | Hold | Maintains | $11 → $10 | +30.38% | Feb 26, 2026 |
| Needham | Needham | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +69.49% | Feb 26, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $10 → $11 | Hold | Maintains | $10 → $11 | +43.42% | Jan 20, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $9 → $10 | Hold | Maintains | $9 → $10 | +30.38% | Dec 2, 2025 |
| JP Morgan | JP Morgan | Sell Maintains $8 → $9 | Sell | Maintains | $8 → $9 | +17.34% | Nov 6, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $9 → $10 | Hold | Maintains | $9 → $10 | +30.38% | Nov 6, 2025 |
| Needham | Needham | Strong Buy Maintains $11 → $12 | Strong Buy | Maintains | $11 → $12 | +56.45% | Nov 6, 2025 |
| UBS | UBS | Hold Maintains $16 → $8 | Hold | Maintains | $16 → $8 | +4.30% | Aug 8, 2025 |
| Stifel | Stifel | Hold Maintains $9 → $8 | Hold | Maintains | $9 → $8 | +4.30% | Aug 8, 2025 |
| Needham | Needham | Strong Buy Maintains $22 → $11 | Strong Buy | Maintains | $22 → $11 | +43.42% | Aug 8, 2025 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $20 → $9 | Buy → Hold | Downgrades | $20 → $9 | +17.34% | Jul 15, 2025 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $24 → $9 | Strong Buy → Hold | Downgrades | $24 → $9 | +17.34% | Jul 10, 2025 |
| B of A Securities | B of A Securities | Sell Maintains $18 → $9 | Sell | Maintains | $18 → $9 | +17.34% | Jul 9, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $18 → $10 | Hold | Maintains | $18 → $10 | +30.38% | Jul 9, 2025 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $25 → $9 | Buy → Hold | Downgrades | $25 → $9 | +17.34% | Jul 9, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.